Stay updated on Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial page.

Latest updates to the Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page's revision tag has been updated to v3.7.0, replacing the previous v3.6.6. This signals that the study record has been refreshed to a newer version.SummaryDifference0.1%

- Check9 days agoChange DetectedA new revision tag Revision: v3.6.6 has been added. Several footer-related items were removed: Bladder cancer, related topics:, MedlinePlus Genetics, and Revision: v3.6.5.SummaryDifference0.2%

- Check23 days agoChange DetectedBladder cancer and a MedlinePlus Genetics entry have been added to the related topics section, linking the study to condition-specific information and genetics resources. This enhances navigational context for users exploring the trial.SummaryDifference0.2%

- Check37 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing the previous v3.6.4; this indicates a minor version update with no apparent changes to the displayed content.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, indicating a software/content update to the ClinicalTrials.gov page without changes to the study details.SummaryDifference0.1%

- Check80 days agoChange DetectedPage revision updated from v3.6.0 to v3.6.3, indicating a newer version of the page template or rendering. This change is a metadata/version update and does not modify the study’s content or user-facing details.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial page.